BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Madan G. Kundu

Madan G. Kundu contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
ApplicationsMethodologyQuantitative Methods

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2020arXiv

Impact of the adjustment of stratification factors on time-to-event analyses

In a stratified clinical trial design with time to event end points, stratification factors are often accounted for the log-rank test and the Cox regression analyses. In this work, we have evaluated the impact of inclusion of stratification factors on the power of the stratified log-rank test and have compared the bias and standard error in HR estimate between multivariate and stratified Cox regression analyses through simulation. Results from our investigation suggests that both failing to consider stratification factor in presence of their prognostic effect and stratification with smaller number of events may substantially reduce the power of the log-rank test. Further, the HR estimate from the multivariate Cox analysis is more accurate and precise compared to the stratified Cox analysis. Our findings point towards the necessity of evaluating the impact of stratification factors on the time to event analyses at the time of study design which is presently not a norm.

0 citations0 reviewsNo code linkedOpen access
preprint2016arXiv

Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: meta-analyses of published studies

Purpose: PFS is often used as a surrogate endpoint for OS in metastatic breast cancer studies. We have evaluated the association of treatment effect on PFS with significant HR$_{OS}$ (and how this association is affected by other factors) in published prospective metastatic breast cancer studies. Methods: A systematic literature search in PubMed identified prospective metastatic breast cancer studies. Treatments effects on PFS were determined using hazard ratio (HR$_{PFS}$), increase in median PFS ($Δ$MED$_{PFS}$) and % increase in median PFS (%$Δ$MED$_{PFS}$). Diagnostic accuracy of PFS measures (HR$_{PFS}$, $Δ$MED$_{PFS}$ and %$Δ$MED$_{PFS}$) in predicting significant HR$_{OS}$ was assessed using receiver operating characteristics (ROC) curves and classification trees approach. Results: Seventy-three cases (i.e., treatment to control comparisons) from 64 individual publications were identified for the analyses. Of these, 16 cases reported significant treatment effect on HR$_{OS}$ at 5% level of significance. Median number of deaths reported in these cases were 156. Area under the ROC curve (AUC) for diagnostic measures as HR$_{PFS}$, $Δ$MED$_{PFS}$ and %$Δ$MED$_{PFS}$ were 0.69, 0.70 and 0.75, respectively. Classification tree results identified %$Δ$MED$_{PFS}$ and number of deaths as diagnostic measure for significant HR$_{OS}$. Only 7.9\% (3/39) cases with $Δ$MED$_{PFS}$ shorter than 48.27\% reported significant HR$_{OS}$. There were 7 cases with $Δ$MED$_{PFS}$ of 48.27\% or more and number of deaths reported as 227 or more -- of these 5 cases reported significant HR$_{OS}$. Conclusion: %$Δ$MED$_{PFS}$ was found as better diagnostic measure for significant HR$_{OS}$. Our analysis results also suggest that consideration of total number of deaths may further improve its diagnostic performance.

0 citations0 reviewsNo code linkedOpen access
preprint2014arXiv

Longitudinal Functional Models with Structured Penalties

This paper addresses estimation in a longitudinal regression model for association between a scalar outcome and a set of longitudinally-collected functional covariates or predictor curves. The framework consists of estimating a time-varying coefficient function that is modeled as a linear combination of time-invariant functions but having time-varying coefficients. The estimation procedure exploits the equivalence between penalized least squares estimation and a linear mixed model representation. The process is empirically evaluated with several simulations and it is applied to analyze the neurocognitive impairment of HIV patients and its association with longitudinally-collected magnetic resonance spectroscopy curves.

0 citations0 reviewsNo code linkedOpen access